Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 18 EP applications Valérie Marie-Noëlle Meyrial has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11769881

THERAPIES FOR IMPROVING PULMONARY FUNCTION

IPC classification:
A61K 39/395, A61P 37/08, C07K 16/24, G01N 33/577
Applicant:
MedImmune Limited
Agent:
AstraZeneca PLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
The patent has been granted
EP11799104

ANTI-IL-18 ANTIBODIES AND THEIR USES

IPC classification:
C07K 16/24
Applicant:
MedImmune Limited
Agent:
Multiple attorneys, MedImmune Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11842005

REGIMENS FOR TREATMENTS USING ANTI-IGF ANTIBODIES

IPC classification:
A61K 39/00, A61K 39/395, C07K 16/22, C12P 21/08
Applicant:
MedImmune, LLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12830128

METHODS FOR PROCESSING COAGULATION FACTORS

IPC classification:
C12P 21/02
Applicant:
MedImmune, LLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
EXAMINATION IN PROGRESS
EP12847479

COMBINATION THERAPIES USING ANTI- PSEUDOMONAS PSL AND PCRV BINDING MOLECULES

IPC classification:
A61K 39/00, A61K 39/395, C07K 16/00, C12P 21/08
Applicant:
MedImmune, LLC
Applicant:
MedImmune Limited
Agent:
Multiple attorneys, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP11813105

METHOD FOR PURIFYING ACTIVE POLYPEPTIDES OR IMMUNOCOJUGATES

IPC classification:
A61K 47/48, B01D 15/04, B01J 41/14, B01J 41/20, C07K 1/18, C07K 16/28
Applicant:
MedImmune, LLC
Agent:
AstraZeneca PLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
EXAMINATION IN PROGRESS
EP13772497

DEVICES HAVING THERMOCHROMIC RESPONSE INDICATORS

IPC classification:
A61J 1/18, A61M 5/50
Applicant:
MedImmune, LLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP11835117

METHODS FOR PROCESSING INCLUSION BODIES

IPC classification:
C07K 1/113, C07K 1/34
Applicant:
MedImmune, LLC
Agent:
AstraZeneca PLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP13848584

STABLE, LOW VISCOSITY ANTIBODY FORMULATION

IPC classification:
A61K 39/395
Applicant:
MedImmune, LLC
Agent:
Graham Matthew Lewis, J A Kemp
Agent:
Multiple attorneys, MedImmune Limited
Status:
GRANT OF PATENT INTENDED
EP14782188

VACCINE COMPOSITION AND METHOD OF USE

IPC classification:
A61K 39/39
Applicant:
MedImmune, LLC
Agent:
AstraZeneca PLC
Agent:
Valérie Marie-Noëlle Meyrial, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP14818351

SEPARATION OF RECOMBINANT POLYCLONAL ANTIBODY MULTIMERS WITH MINIMAL SEPARATION OF MONOMERS

IPC classification:
C07K 16/00
Applicant:
MedImmune, LLC
Agent:
AstraZeneca PLC
Agent:
Valérie Marie-Noëlle Meyrial, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP11761051

FACTOR II ALONE OR IN COMBIATION WITH FURTHER FACTORS FOR TREATMENT OF IMPAIRED HAEMOSTASIS ASSOCIATED WITH DILUTIONAL COAGULOPATHY

IPC classification:
A61K 38/36, A61K 38/48, A61P 7/04
Applicant:
MedImmune Limited
Agent:
AstraZeneca PLC
Agent:
Multiple attorneys, MedImmune Limited
Status:
PATENT GRANTED
EP15740660

DIPEPTIDYL PEPTIDASE-4 (DPP4/CD26) AS A PERIPHERAL BIOMARKER OF IL-13 ACTIVATION IN ASTHMATIC LUNG

IPC classification:
A61K 39/395, G01N 33/53, G01N 33/573
Applicant:
MedImmune, LLC
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Agent:
Valérie Marie-Noëlle Meyrial, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP15773468

METHODS FOR ENHANCING THE EFFICACY OF A TUMOR-DIRECTED IMMUNE RESPONSE

IPC classification:
A61K 39/39, A61P 37/02
Applicant:
Augusta University Research Institute, Inc.
Agent:
AstraZeneca PLC
Agent:
Valérie Marie-Noëlle Meyrial, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP15777404

BISPECIFIC HER2 ANTIBODIES

IPC classification:
A61K 39/395, A61K 45/06, C07K 16/40
Agent:
AstraZeneca PLC
Agent:
Valérie Marie-Noëlle Meyrial, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP15789548

MULTI-SPECIFIC ANTI-PSEUDOMONAS PSL AND PCRV BINDING MOLECULES AND USES THEREOF

IPC classification:
A61K 39/00, A61K 39/40, C07H 21/04, C07K 16/00, C12P 21/08
Applicant:
MedImmune Limited
Agent:
AstraZeneca PLC
Agent:
Valérie Marie-Noëlle Meyrial, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP15725113

PROCESSES FOR THE PREPARATION OF AZD5363 AND NOVEL INTERMEDIATE USED THEREIN

IPC classification:
C07D 487/04, C07D 498/10
Applicant:
AstraZeneca AB
Agent:
Mark David Ness, AstraZeneca AB
Agent:
AstraZeneca PLC
Agent:
Valérie Marie-Noëlle Meyrial, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP15771960

ANTIBODIES TO TICAGRELOR AND METHODS OF USE

IPC classification:
C07D 487/04, C07K 16/44
Applicant:
MedImmune Limited
Agent:
AstraZeneca PLC
Agent:
Valérie Marie-Noëlle Meyrial, MedImmune Limited
Status:
Request for examination was made

Please Sign in to use this feature